1. Home
  2. XGN

XGN

Exagen Inc.

Logo Exagen Inc.

Health Care

Medical Specialities

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Founded: N/A Country:
United States
United States
Employees: 179 City: VISTA
Market Cap: 24.7M IPO Year: 2019
Target Price: $6.00 AVG Volume (30 days): 41.3K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.34 EPS Growth: N/A
52 Week Low/High: $1.33 - $3.92 Next Earning Date: 05-13-2024
Revenue: $52,548,000 Revenue Growth: 15.33%
Revenue Growth (this year): 4.1% Revenue Growth (next year): 16.16%

Share on Social Networks: